Suratadenoturev API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Suratadenoturev is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Suratadenoturev or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Suratadenoturev API 1268642-13-2?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Suratadenoturev. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Suratadenoturev
- Synonyms:
- A recombinant replication-competent adenovirus type 5 (Ad-5) in which the E1 gene, including its normal transcriptional regulatory element, has been deleted and replaced by an expression cassette containing an hTERT (human telomerase reverse transcriptas , A replication-competent adenovirus type 5 in which the E1A and E1B genes are under the control of a human telomerase reverse transcriptase (hTERT) and IRES, respectively. , DNA (recombinant human telomerase-specific replication-competent oncolytic adenovirus 5 vector OBP-301) , Telomelysin , Telomerase Specific Replication-competent Oncolytic Adenovirus
- Cas Number:
- 1268642-13-2
- DrugBank number:
- DB18672
- Unique Ingredient Identifier:
- FV0JG1SX76
General Description:
Suratadenoturev, identified by CAS number 1268642-13-2, is a notable compound with significant therapeutic applications. Suratadenoturev is a gene-modified oncolytic adenovirus expressing the telomerase reverse transcriptase gene.
